Sqz Biotechnologies Co News

SQZDelisted Stock  USD 0.10  0.04  28.57%   
Slightly above 62% of Sqz Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Sqz Biotechnologies Co suggests that many traders are alarmed regarding Sqz Biotechnologies' prospects. Sqz Biotechnologies' investing sentiment can be driven by a variety of factors including economic data, Sqz Biotechnologies' earnings reports, geopolitical events, and overall market trends.
  
over a week ago at investing.com         
An2 therapeutics CEO Eric Easom acquires 49,970 in stock
Investing News at Macroaxis
over two weeks ago at newsweek.com         
Michael Strahan responds to National Anthem backlash
news
over a month ago at businesswire.com         
Anthem Blue Cross and Blue Shield Foundation and McShin Foundation Expand Support for Virginians in ...
businesswire News
over a year ago at insidermonkey.com         
Miromatrix Medical Inc. Q1 2023 Earnings Call Transcript
insidermonkey News
over a year ago at news.google.com         
UPDATE 5-JJ expects cancer drugs, medical devices to drive growth in 2023 - Yahoo Finance
Google News at Macroaxis
over a month ago at benzinga.com         
Why Inhibikase Therapeutics Stock Is Up 50 percent Today
benzinga news
over a month ago at gurufocus.com         
Director Arvind Kush Acquires 145,000 Shares of Inhibikase Therapeutics Inc
Gurufocus Stories at Macroaxis
over a month ago at globenewswire.com         
Insider Trading
Macroaxis News: globenewswire.com
over a month ago at finance.yahoo.com         
PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial
Yahoo News
over a week ago at news.google.com         
PMV Pharmaceuticals files 200M mixed securities shelf - TipRanks
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by English Aron R. of 714250 shares of Anebulo Pharmaceuticals at 7.0 subject to Rule 16...
Macroaxis News
over a week ago at news.google.com         
Anebulo Pharmaceuticals Advances Cannabis Toxicity Solutions - MSN
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Ellias Helen K. of 20000 shares of SAB Biotherapeutics at 3.88 subject to Rule 16b-3
Macroaxis News
over two months ago at accesswire.com         
SHAREHOLDER ALERT Levi Korsinsky, LLP Informs Shareholders of an Investigation into SAB Biotherap
news
over a month ago at seekingalpha.com         
Processa Pharmaceuticals GAAP EPS of -1.03
seekingalpha News
over two months ago at www.macroaxis.com         
Acquisition by Bigora Sian of 1675 shares of Processa Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over two weeks ago at gurufocus.com         
Biotechnology Value Fund L.P. Expands Stake in Third Harmonic Bio Inc.
Gurufocus Stories at Macroaxis
over two months ago at finance.yahoo.com         
Third Harmonic Bio Is In A Strong Position To Grow Its Business
Yahoo News
over a month ago at www.macroaxis.com         
Disposition of 2673 shares by Conner Edward R. of Third Harmonic at 15.0 subject to Rule 16b-3
Macroaxis News
over a month ago at globenewswire.com         
Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit
Macroaxis News: globenewswire.com
over two months ago at news.google.com         
Lipella Pharmaceuticals announces board election and reverse stock split - Investing.com India
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Li...
Yahoo News
over two weeks ago at globenewswire.com         
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
Macroaxis News: globenewswire.com
over a week ago at news.google.com         
Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septemb...
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 400000 shares by Hackman Jeffrey S. of Fennec Pharmaceuticals at 5.58 subject to Rule...
Macroaxis News
over two weeks ago at insidermonkey.com         
Disposition of 400000 shares by Hackman Jeffrey S. of Fennec Pharmaceuticals at 5.58 subject to Rule...
insidermonkey News
over two weeks ago at investing.com         
Monopar Therapeutics stock target lifted, buy rating on AstraZeneca deal
Investing News at Macroaxis
over a month ago at gurufocus.com         
Monopar Therapeutics Shares Surge on Partnership with Alexion
Gurufocus Stories at Macroaxis
over a month ago at globenewswire.com         
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
Macroaxis News: globenewswire.com
over a year ago at news.google.com         
Insider Transaction at Applied Molecular Board Member Granted ... - Best Stocks
Google News at Macroaxis
over a year ago at marketwatch.com         
Neoleukin Therapeutics Shares Rise Premarket on Reverse Merger Deal NLTX
marketwatch News
over a year ago at news.google.com         
Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2HER3 Solid Tu...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Hillstream BioPharma, Inc. Short Interest Update
news
few days ago at simplywall.st         
Fujian Wanchen Biotechnology Group Co., Ltd. Delivered A Better ROE Than Its Industry
Simply Wall St News at Macroaxis
over two weeks ago at finance.yahoo.com         
PDS Biotechnology Corp Q3 2024 Earnings Call Highlights Navigating Financial Challenges ...
Yahoo News
over a week ago at thelincolnianonline.com         
Generex Biotechnology Shares Cross Above 200 Day Moving Average Should You Sell?
news
over a month ago at www.macroaxis.com         
Disposition of 1597 shares by Aguilar-cordova Estuardo of Candel Therapeutics at 5.8 subject to Rule...
Macroaxis News
over three weeks ago at globenewswire.com         
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 ...
Macroaxis News: globenewswire.com
over a month ago at investing.com         
Candel therapeutics investor sells 243,834 in stock
Investing News at Macroaxis
over a week ago at gurufocus.com         
Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancers th Annual Meeti...
Yahoo News
over two weeks ago at thelincolnianonline.com         
Kezar Life Sciences Market Perform Rating Reaffirmed at William Blair
news
over three weeks ago at zacks.com         
VistaGen Therapeutics, Inc. Reports Q2 Loss, Misses Revenue Estimates
zacks News
over a month ago at businesswire.com         
Kezar Life Sciences Announces 1-for-10 Reverse Stock Split
businesswire News
over a month ago at stockhead.com.au         
ASX Small Caps Lunch Wrap No rest for ASX on Labour Day as benchmark inches higher
news
over two weeks ago at gurufocus.com         
FMR LLC Bolsters Stake in Nuvation Bio Inc
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 56361 shares by Junyuan Wang of Nuvation Bio at 2.89 subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
Is Nuvation Bio Inc. the Hottest Penny Stock to Invest in According to Hedge Funds?
Yahoo News
over a month ago at investing.com         
Nuvation Bio director acquires 220k in company stock
Investing News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Sqz Biotechnologies that are available to investors today. That information is available publicly through Sqz media outlets and privately through word of mouth or via Sqz internal channels. However, regardless of the origin, that massive amount of Sqz data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sqz Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sqz Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sqz Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sqz Biotechnologies alpha.

Sqz Biotechnologies Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Sqz Bio earnings missed by 0.09, revenue fell short of estimates
05/11/2023
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Sqz Stock

If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamental Analysis
View fundamental data based on most recent published financial statements